ReAliZe and OncoSTART have signed a partnership for the benefit of oncology startups. Startups in the ReAliZe program will notably be able to benefit from the additional training modules offered by the OncoSTART consortium.

Led by AstraZeneca, ReAliZe is a personalized acceleration program to support French startups in the deployment of innovative solutions in oncology through a collaborative approach.

For the 3rd Edition, the winning startups of the ReAliZe program are: